These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 8546199)

  • 1. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions.
    Li Z; Li L; Zielke HR; Cheng L; Xiao R; Crow MT; Stetler-Stevenson WG; Froehlich J; Lakatta EG
    Am J Pathol; 1996 Jan; 148(1):121-8. PubMed ID: 8546199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture.
    Shah PK; Falk E; Badimon JJ; Fernandez-Ortiz A; Mailhac A; Villareal-Levy G; Fallon JT; Regnstrom J; Fuster V
    Circulation; 1995 Sep; 92(6):1565-9. PubMed ID: 7664441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases. Their role in degenerative chronic diseases of abdominal aorta.
    Palombo D; Maione M; Cifiello BI; Udini M; Maggio D; Lupo M
    J Cardiovasc Surg (Torino); 1999 Apr; 40(2):257-60. PubMed ID: 10350113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats.
    Takahara T; Furui K; Funaki J; Nakayama Y; Itoh H; Miyabayashi C; Sato H; Seiki M; Ooshima A; Watanabe A
    Hepatology; 1995 Mar; 21(3):787-95. PubMed ID: 7875677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth.
    Luttun A; Lutgens E; Manderveld A; Maris K; Collen D; Carmeliet P; Moons L
    Circulation; 2004 Mar; 109(11):1408-14. PubMed ID: 14993123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gelatinase expression and activity in the synovium and skin of patients with erosive psoriatic arthritis.
    Hitchon CA; Danning CL; Illei GG; El-Gabalawy HS; Boumpas DT
    J Rheumatol; 2002 Jan; 29(1):107-17. PubMed ID: 11824946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinase-2 activation in human hepatic fibrosis regulation by cell-matrix interactions.
    Préaux AM; Mallat A; Nhieu JT; D'Ortho MP; Hembry RM; Mavier P
    Hepatology; 1999 Oct; 30(4):944-50. PubMed ID: 10498646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value.
    Väisänen A; Tuominen H; Kallioinen M; Turpeenniemi-Hujanen T
    J Pathol; 1996 Nov; 180(3):283-9. PubMed ID: 8958806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between 5-lipoxygenase expression and plaque instability in humans.
    Cipollone F; Mezzetti A; Fazia ML; Cuccurullo C; Iezzi A; Ucchino S; Spigonardo F; Bucci M; Cuccurullo F; Prescott SM; Stafforini DM
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1665-70. PubMed ID: 15933245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
    Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
    Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions.
    Kalinina N; Agrotis A; Antropova Y; Ilyinskaya O; Smirnov V; Tararak E; Bobik A
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1391-6. PubMed ID: 15166010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.
    Janowska-Wieczorek A; Marquez LA; Matsuzaki A; Hashmi HR; Larratt LM; Boshkov LM; Turner AR; Zhang MC; Edwards DR; Kossakowska AE
    Br J Haematol; 1999 May; 105(2):402-11. PubMed ID: 10233411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
    Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
    Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
    Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
    Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catechins prevent vascular smooth muscle cell invasion by inhibiting MT1-MMP activity and MMP-2 expression.
    El Bedoui J; Oak MH; Anglard P; Schini-Kerth VB
    Cardiovasc Res; 2005 Aug; 67(2):317-25. PubMed ID: 15885676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas.
    Inaki N; Tsunezuka Y; Kawakami K; Sato H; Takino T; Oda M; Watanabe G
    J Heart Lung Transplant; 2004 Feb; 23(2):218-27. PubMed ID: 14761770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of activated matrix metalloproteinase-2 by human endothelial cells after sublethal H2O2 exposure.
    Belkhiri A; Richards C; Whaley M; McQueen SA; Orr FW
    Lab Invest; 1997 Nov; 77(5):533-9. PubMed ID: 9389796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system.
    Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D
    Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis.
    Montero I; Orbe J; Varo N; Beloqui O; Monreal JI; Rodríguez JA; Díez J; Libby P; Páramo JA
    J Am Coll Cardiol; 2006 Apr; 47(7):1369-78. PubMed ID: 16580524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.